3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
10
Neoplasms
7
Motor Activity
5
Rectal Neoplasms
3
Pain, Postoperative
3
Vomiting
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Nausea
2
Lung Neoplasms
2
Liver Diseases
2
Leukemia, Myeloid, Acute
2
Fatigue
2
Colorectal Neoplasms
2
Agnosia
2
Uterine Cervical Neoplasms
1
Ulcer
1
Stomatitis
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sleep Initiation and Maintenance Disorders
1
Postoperative Cognitive Complications
1
Polycystic Ovary Syndrome
1
Peripheral Nervous System Diseases
1
Pediatric Brain Tumor
1
Pathologic Processes
1
Papillomavirus Infections
1
Pain
1
Osteolysis
1
Multiple Myeloma
1
Malnutrition
1
Interventions
Methods
2
pomalidomide
1
fasudil
1
XENP 1595
1
UE2343
1
Transurethral Resection of Bladder
1
Telemedicine
1
Surgical Procedures, Operative
1
Standard of Care
1
Hormones
1
Exercise
1
Ethanol
1
Electroencephalography
1
Drug Delivery Systems
1
Dexamethasone
1
Control Groups
1
Amputation, Surgical
1
7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Alzheimer Disease
×
Control Groups
×
1 year
×
Clear all
NCT03282097
2025-08-11
DECAD
Indiana University
Phase NA
Completed
442 enrolled
13 charts